(Q44538413)

3 December 2017

title

Association between inflammatory mediators and muscle mass in long-term hemodialysis patients (English)

1 reference

3 December 2017

0 references

1 reference

Yukiko Kaizu

1

1 reference

3 December 2017

Sakae Ohkawa

2

1 reference

3 December 2017

Mari Odamaki

3

1 reference

3 December 2017

Naoki Ikegaya

4

1 reference

3 December 2017

Ikuo Hibi

5

1 reference

3 December 2017

Kunihiko Miyaji

6

1 reference

3 December 2017

Hiromichi Kumagai

7

1 reference

3 December 2017

language of work or name

1 reference

1 August 2003

1 reference

American Journal of Kidney Diseases

3 December 2017

published in

1 reference

3 December 2017

volume

42

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

295-302

1 reference

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Effect of nutrition on morbidity and mortality in maintenance dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Muscle mass: reliable indicator of protein-energy malnutrition severity and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Standardized thigh muscle area measured by computed axial tomography as an alternate muscle mass index for nutritional assessment of hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

New method to calculate creatinine generation rate using pre- and postdialysis creatinine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Muscle mass index in haemodialysis patients: a comparison of indices obtained by routine clinical examinations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Interleukin-6 down-regulates expressions of the aldolase B and albumin genes through a pathway involving the activation of tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Interleukin-6 may mediate malnutrition in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Interleukin-6 induces skeletal muscle protein breakdown in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Simple nutritional indicators as independent predictors of mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Malnutrition in long-term haemodialysis survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Inflammatory signals associated with hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Creatinine generation rate and lean body mass: a critical analysis in peritoneal dialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Mechanisms of loss of lean body mass in patients on chronic dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Effect of L-carnitine supplementation in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900654-1

7 January 2021

10.1016/S0272-6386(03)00654-1

Identifiers

DOI

1 reference

3 December 2017

1 reference